DOI 10.1016/j.hrthm.2026.05.034
Subcutaneous ICD therapy in patients with monomorphic ventricular tachycardia: Arrhythmia recurrence, shock rate, and management strategies.
Аннотация
BACKGROUND
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is recommended for patients at risk of sudden cardiac death who do not require pacing or antitachycardia pacing (ATP). However, patients with a history of monomorphic ventricular tachycardia (MVT), which is often amenable to ATP, are underrepresented in clinical studies dealing with S-ICD.
OBJECTIVE
This study aimed to evaluate outcomes of S-ICD therapy in patients with previous MVT and describe subsequent management strategies in clinical practice.
METHODS
From 2164 consecutive de novo S-ICD implantations, we identified 210 patients (10%) with a history of sustained MVT. Clinical characteristics, procedural data, and outcomes were analyzed. The endpoints of the study included the rates of sustained MVT and S-ICD shocks for all ventricular arrhythmias.
RESULTS
During a median follow-up of 43 months (interquartile range 21-70), 21 patients (10%) experienced 66 MVT episodes (60 isolated, 6 storms) and a total of 98 ventricular arrhythmic episodes, all successfully terminated by shocks. The annualized rate of MVT was 2.8%/y, and the rate of appropriate shocks was 4.9%/y. First-shock efficacy was 93% for both MVT and polymorphic ventricular tachycardia/ventricular fibrillation. Approximately half of patients with recurrent MVT underwent ablation, with high procedural success. No patient required S-ICD explantation or conversion to a transvenous implantable cardioverter-defibrillator for ATP delivery. The complication rate was 2.3%/y and the inappropriate shock rate 2.8%/y.
CONCLUSION
In patients with previous MVT, the S-ICD provided safe and effective protection against ventricular arrhythmias. Ablation was the preferred management strategy, and no patients required conversion to a transvenous device. These findings support the use of the S-ICD as a viable option in this patient population.
CLINICAL TRIAL REGISTRATION: URL: http://clinicaltrials.gov/ identifier: NCT02275637.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.